日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and Efficacy of Fecal Microbiota, Live-jslm for Prevention of Recurrent Clostridioides difficile Infection Among Hospitalized Participants in PUNCH CD3-OLS

粪便微生物群 Live-jslm 在 PUNCH CD3-OLS 研究中预防住院患者复发性艰难梭菌感染的安全性和有效性

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-026-01304-9
Skinner, Andrew M; Lodise, Thomas P; Reilly, Joseph; Guthmueller, Beth; Srivastava, Shivam; Axelrad, Jordan E
炎症/感染
CD3
微生物学
发表日期：2026
文献求助 收藏

PUNCH CD3-OLS: A Phase 3 Prospective Observational Cohort Study to Evaluate the Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA) in Adults With Recurrent Clostridioides difficile Infection

PUNCH CD3-OLS：一项评估粪便微生物群、活体jslm（REBYOTA）治疗复发性艰难梭菌感染成人患者的安全性和有效性的3期前瞻性观察队列研究

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciae437
Feuerstadt, Paul; Chopra, Teena; Knapple, Whitfield; Van Hise, Nicholas W; Dubberke, Erik R; Baggott, Brian; Guthmueller, Beth; Bancke, Lindy; Gamborg, Michael; Steiner, Theodore S; Van Handel, Daniel; Khanna, Sahil
炎症/感染
CD3
微生物学
发表日期：2025
文献求助 收藏

Safety and Efficacy of Fecal Microbiota, Live-jslm to Prevent Recurrent Clostridioides difficile Infection in Participants With Irritable Bowel Syndrome

粪便微生物群 Live-jslm 预防肠易激综合征患者复发性艰难梭菌感染的安全性和有效性

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-025-01208-0
Aroniadis, Olga C; Guthmueller, Beth; Dehlin, Kaitlin; Srivastava, Shivam; Feuerstadt, Paul; Lembo, Anthony; Weber, Horst C
肠易激综合征
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Safety and Efficacy of Fecal Microbiota, Live-jslm, in Preventing Recurrent Clostridioides difficile Infection in Participants Who Were Mildly to Moderately Immunocompromised in the Phase 3 PUNCH CD3-OLS Study

在 PUNCH CD3-OLS 3 期研究中，评估了粪便微生物群 Live-jslm 在预防轻度至中度免疫功能低下受试者复发性艰难梭菌感染方面的安全性和有效性。

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofaf117
Alonso, Carolyn D; Tillotson, Glenn S; Bidell, Monique R; Guthmueller, Beth; Hoeyer, Frederikke; Fischer, Monika; Dubberke, Erik R
炎症/感染
CD3
免疫/内分泌
微生物学
发表日期：2025
文献求助 收藏

Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA(®)) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trial

通过结肠镜给予粪便微生物活体jslm（REBYOTA®）预防复发性艰难梭菌感染的安全性和有效性：一项单臂IIIb期试验CDI-SCOPE的8周结果

期刊:
影响因子:
doi:10.1177/17562848251339697
Khanna, Sahil; Yoho, David; Van Handel, Daniel; Clark, Brian J; Awad, Tahany; Guthmueller, Beth; Armandi, Daniel; Knapple, Whitfield; Safdar, Nasia; Baggott, Brian; Simon, Karen; Feuerstadt, Paul
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA(®)) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial

通过结肠镜给予粪便微生物活菌（REBYOTA®）预防复发性艰难梭菌感染：单臂 IIIb 期 CDI-SCOPE 试验的 6 个月数据

期刊:
影响因子:
doi:10.1177/17562848251396744
Khanna, Sahil; Yoho, David; Van Handel, Daniel; Clark, Brian J; Awad, Tahany; Guthmueller, Beth; Armandi, Daniel; Knapple, Whitfield; Safdar, Nasia; Baggott, Brian; Simon, Karen; Feuerstadt, Paul
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent Clostridioides difficile infection from five prospective clinical trials: an update

五项前瞻性临床试验中，对粪便微生物群和活体JSLM在复发性艰难梭菌感染成人患者中的安全性进行综合分析：最新进展

期刊:
影响因子:
doi:10.1177/17562848251395566
Lee, Christine; Feuerstadt, Paul; Louie, Thomas; Bancke, Lindy; Guthmueller, Beth; Harvey, Adam; Hoeyer, Frederikke; Orenstein, Robert; Dubberke, Erik R; Khanna, Sahil
炎症/感染
微生物学
发表日期：2025
文献求助 收藏

Patient-reported benefits of colonoscopicallyadministered microbiota restoration therapy: a qualitative study of adult patients with recurrent Clostridioides difficile infection

结肠镜下肠道菌群重建疗法的患者报告获益：一项针对复发性艰难梭菌感染成年患者的定性研究

期刊:
影响因子:
doi:10.1177/17562848251392102
McCool-Myers, Megan; Umanzor-Figueroa, Cindy; Symonds, Tara; Landeira, Margarita; Awad, Tahany; Armandi, Daniel; Guthmueller, Beth; Khanna, Sahil
炎症/感染
肠道菌群
微生物学
发表日期：2025
文献求助 收藏

Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), Among Patients Exposed to Non-Clostridioides difficile Infection Antibiotics: Post Hoc Subgroup Analysis of a Phase 2 Open-Label Study

粪便微生物群 Live-jslm (REBYOTA®) 在接受非艰难梭菌感染抗生素治疗的患者中的疗效：一项 2 期开放标签研究的事后亚组分析

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofae341
Reveles, Kelly R; Gonzales-Luna, Anne J; Golan, Yoav; Alonso, Carolyn D; Guthmueller, Beth; Tan, Xing; Bidell, Monique R; Pokhilko, Victoria; Crawford, Carl V; Skinner, Andrew M
炎症/感染
微生物学
发表日期：2024
文献求助 收藏

Fecal Microbiota, Live-jslm for the Prevention of Recurrent Clostridioides difficile Infection : Subgroup Analysis of PUNCH CD2 and PUNCH CD3

粪便微生物群，Live-jslm 用于预防复发性艰难梭菌感染：PUNCH CD2 和 PUNCH CD3 亚组分析

期刊:Journal of Clinical Gastroenterology
影响因子:2.7
doi:10.1097/MCG.0000000000001947
Feuerstadt, Paul; Crawford, Carl V; Tan, Xing; Pokhilko, Victoria; Bancke, Lindy; Ng, Samson; Guthmueller, Beth; Bidell, Monique R; Tillotson, Glenn; Johnson, Stuart; Skinner, Andrew M
炎症/感染
CD3
CD2
微生物学
发表日期：2024
文献求助 收藏